tiprankstipranks
Humana Inc (CH:HUM)
:HUM
Switzerland Market
HUM
Humana
RESEARCH TOOLSreports

Humana (HUM) Stock Forecast & Price Target

3 Followers
See the Price Targets and Ratings of:

HUM Analyst Ratings

Moderate Buy
23Ratings
Moderate Buy
11 Buy
11 Hold
1 Sell
Based on 23 analysts giving stock ratings to
Humana
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

HUM Stock 12 Month Forecast

Average Price Target

―
Based on 23 Wall Street analysts offering 12 month price targets for Humana in the last 3 months. The average price target is CHF348.16 with a high forecast of CHF505.39 and a low forecast of CHF226.78. The average price target represents a ― change from the last price of ―.
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
Highest Price TargetCHF505.39Average Price TargetCHF348.16Lowest Price TargetCHF226.78
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
J.P. Morgan Analyst forecast on CH:HUM
Lisa Gill
J.P. Morgan
J.P. Morgan
CHF255.94→CHF318.3
Hold
―
Assigned
08/10/26
Humana price target raised to $393 from $316 at JPMorganHumana price target raised to $393 from $316 at JPMorgan
Bank of America Securities Analyst forecast on CH:HUM
Kevin Fischbeck
Bank of America Securities
Bank of America Securities
CHF404.96
Buy
―
Reiterated
08/07/26
Analysts Offer Insights on Healthcare Companies: AMN Healthcare Services (NYSE: AMN), Maravai Lifesciences Holdings (NASDAQ: MRVI) and Humana (NYSE: HUM)
Morgan Stanley Analyst forecast on CH:HUM
Erin Wright
Morgan Stanley
Morgan Stanley
CHF201.67→CHF299.67
Hold
―
Upgraded
08/05/26
Humana upgraded to Equal Weight from Underweight at Morgan StanleyHumana upgraded to Equal Weight from Underweight at Morgan Stanley
TD Cowen Analyst forecast on CH:HUM
Ryan Langston
TD Cowen
TD Cowen
CHF283.47→CHF299.67
Hold
―
Assigned
07/31/26
Humana Price Target Raised to $370 as Margin Recovery Prospects Balance Ongoing Execution Risks, Supporting Hold Rating
Barclays Analyst forecast on CH:HUM
Andrew Mok CFA
Barclays
Barclays
CHF278.61→CHF329.64
Hold
―
Reiterated
07/31/26
Humana (HUM) Receives a Hold from Barclays
Truist Financial Analyst forecast on CH:HUM
David S Macdonald
Truist Financial
Truist Financial
CHF336.12
Hold
―
Reiterated
07/30/26
Analysts' Top Healthcare Picks: Tilray (TLRY), Humana (HUM)
UBS Analyst forecast on CH:HUM
A.J. Rice
UBS
UBS
CHF259.18→CHF328.02
Hold
―
Reiterated
07/30/26
UBS Remains a Hold on Humana (HUM)
Oppenheimer Analyst forecast on CH:HUM
Michael Wiederhorn
Oppenheimer
Oppenheimer
CHF275.37→CHF328.02
Buy
―
Assigned
07/30/26
Humana price target raised to $405 from $340 at OppenheimerHumana price target raised to $405 from $340 at Oppenheimer
Deutsche Bank Analyst forecast on CH:HUM
George Hill
Deutsche Bank
Deutsche Bank
CHF357.18→CHF353.13
Buy
―
Reiterated
07/30/26
Humana price target lowered to $436 from $441 at Deutsche BankHumana price target lowered to $436 from $441 at Deutsche Bank
Goldman Sachs Analyst forecast on CH:HUM
Scott Fidel
Goldman Sachs
Goldman Sachs
CHF157.94→CHF226.78
Sell
―
Reiterated
07/30/26
Analysts Offer Insights on Healthcare Companies: GE Healthcare Technologies Inc (NASDAQ: GEHC), Humana (NYSE: HUM) and Ocular Therapeutix (NASDAQ: OCUL)
Leerink Partners Analyst forecast on CH:HUM
Whit Mayo
Leerink Partners
Leerink Partners
CHF206.53→CHF415.49
Buy
―
Upgraded
07/30/26
Humana price target raised to $513 from $255 at LeerinkHumana price target raised to $513 from $255 at Leerink
KeyBanc Analyst forecast on CH:HUM
Matthew Gillmor CFA
KeyBanc
KeyBanc
―
Hold
―
Reiterated
07/30/26
Analysts Offer Insights on Healthcare Companies: Adaptive Biotechnologies (NASDAQ: ADPT), Humana (NYSE: HUM) and Teladoc (NYSE: TDOC)
Raymond James Analyst forecast on CH:HUM
Parker Snure
Raymond James
Raymond James
CHF344.22
Hold
―
Downgraded
07/30/26
Humana downgraded to Market Perform from Outperform at Raymond JamesHumana downgraded to Market Perform from Outperform at Raymond James
Piper Sandler Analyst forecast on CH:HUM
Jessica Tassan
Piper Sandler
Piper Sandler
CHF205.72→CHF375
Buy
―
Upgraded
07/30/26
Humana upgraded to Overweight from Neutral at Piper SandlerHumana upgraded to Overweight from Neutral at Piper Sandler
Robert W. Baird Analyst forecast on CH:HUM
Michael Ha
Robert W. Baird
Robert W. Baird
CHF166.03→CHF315.87
Hold
―
Reiterated
07/30/26
Humana price target raised to $390 from $205 at BairdHumana price target raised to $390 from $205 at Baird
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
J.P. Morgan Analyst forecast on CH:HUM
Lisa Gill
J.P. Morgan
J.P. Morgan
CHF255.94→CHF318.3
Hold
―
Assigned
08/10/26
Humana price target raised to $393 from $316 at JPMorganHumana price target raised to $393 from $316 at JPMorgan
Bank of America Securities Analyst forecast on CH:HUM
Kevin Fischbeck
Bank of America Securities
Bank of America Securities
CHF404.96
Buy
―
Reiterated
08/07/26
Analysts Offer Insights on Healthcare Companies: AMN Healthcare Services (NYSE: AMN), Maravai Lifesciences Holdings (NASDAQ: MRVI) and Humana (NYSE: HUM)
Morgan Stanley Analyst forecast on CH:HUM
Erin Wright
Morgan Stanley
Morgan Stanley
CHF201.67→CHF299.67
Hold
―
Upgraded
08/05/26
Humana upgraded to Equal Weight from Underweight at Morgan StanleyHumana upgraded to Equal Weight from Underweight at Morgan Stanley
TD Cowen Analyst forecast on CH:HUM
Ryan Langston
TD Cowen
TD Cowen
CHF283.47→CHF299.67
Hold
―
Assigned
07/31/26
Humana Price Target Raised to $370 as Margin Recovery Prospects Balance Ongoing Execution Risks, Supporting Hold Rating
Barclays Analyst forecast on CH:HUM
Andrew Mok CFA
Barclays
Barclays
CHF278.61→CHF329.64
Hold
―
Reiterated
07/31/26
Humana (HUM) Receives a Hold from Barclays
Truist Financial Analyst forecast on CH:HUM
David S Macdonald
Truist Financial
Truist Financial
CHF336.12
Hold
―
Reiterated
07/30/26
Analysts' Top Healthcare Picks: Tilray (TLRY), Humana (HUM)
UBS Analyst forecast on CH:HUM
A.J. Rice
UBS
UBS
CHF259.18→CHF328.02
Hold
―
Reiterated
07/30/26
UBS Remains a Hold on Humana (HUM)
Oppenheimer Analyst forecast on CH:HUM
Michael Wiederhorn
Oppenheimer
Oppenheimer
CHF275.37→CHF328.02
Buy
―
Assigned
07/30/26
Humana price target raised to $405 from $340 at OppenheimerHumana price target raised to $405 from $340 at Oppenheimer
Deutsche Bank Analyst forecast on CH:HUM
George Hill
Deutsche Bank
Deutsche Bank
CHF357.18→CHF353.13
Buy
―
Reiterated
07/30/26
Humana price target lowered to $436 from $441 at Deutsche BankHumana price target lowered to $436 from $441 at Deutsche Bank
Goldman Sachs Analyst forecast on CH:HUM
Scott Fidel
Goldman Sachs
Goldman Sachs
CHF157.94→CHF226.78
Sell
―
Reiterated
07/30/26
Analysts Offer Insights on Healthcare Companies: GE Healthcare Technologies Inc (NASDAQ: GEHC), Humana (NYSE: HUM) and Ocular Therapeutix (NASDAQ: OCUL)
Leerink Partners Analyst forecast on CH:HUM
Whit Mayo
Leerink Partners
Leerink Partners
CHF206.53→CHF415.49
Buy
―
Upgraded
07/30/26
Humana price target raised to $513 from $255 at LeerinkHumana price target raised to $513 from $255 at Leerink
KeyBanc Analyst forecast on CH:HUM
Matthew Gillmor CFA
KeyBanc
KeyBanc
―
Hold
―
Reiterated
07/30/26
Analysts Offer Insights on Healthcare Companies: Adaptive Biotechnologies (NASDAQ: ADPT), Humana (NYSE: HUM) and Teladoc (NYSE: TDOC)
Raymond James Analyst forecast on CH:HUM
Parker Snure
Raymond James
Raymond James
CHF344.22
Hold
―
Downgraded
07/30/26
Humana downgraded to Market Perform from Outperform at Raymond JamesHumana downgraded to Market Perform from Outperform at Raymond James
Piper Sandler Analyst forecast on CH:HUM
Jessica Tassan
Piper Sandler
Piper Sandler
CHF205.72→CHF375
Buy
―
Upgraded
07/30/26
Humana upgraded to Overweight from Neutral at Piper SandlerHumana upgraded to Overweight from Neutral at Piper Sandler
Robert W. Baird Analyst forecast on CH:HUM
Michael Ha
Robert W. Baird
Robert W. Baird
CHF166.03→CHF315.87
Hold
―
Reiterated
07/30/26
Humana price target raised to $390 from $205 at BairdHumana price target raised to $390 from $205 at Baird
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
BTSGBrightSpring Health Services, Inc.
AMLXAmylyx Pharmaceuticals Inc
IMMXImmix Biopharma
TNYATenaya Therapeutics
JBIOJade Biosciences
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Humana

3 Months
Michael WiederhornOppenheimer
Success Rate
26/40 ratings generated profit
65%
Average Return
+3.76%
Copying Michael Wiederhorn's trades and holding each position for 3 Months would result in 65.00% of your transactions generating a profit, with an average return of +3.76% per trade.
1 Year
Michael WiederhornOppenheimer
Success Rate
25/40 ratings generated profit
63%
Average Return
+9.51%
Copying Michael Wiederhorn's trades and holding each position for 1 Year would result in 62.50% of your transactions generating a profit, with an average return of +9.51% per trade.
2 Years
Michael WiederhornOppenheimer
Success Rate
32/40 ratings generated profit
80%
Average Return
+19.95%
Copying Michael Wiederhorn's trades and holding each position for 2 Years would result in 80.00% of your transactions generating a profit, with an average return of +19.95% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

HUM Analyst Recommendation Trends

Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
0
0
0
1
1
Buy
11
11
13
17
14
Hold
34
19
24
23
20
Sell
4
2
3
4
3
Strong Sell
0
0
0
0
0
total
49
32
40
45
38
In the current month, HUM has received 15 Buy Ratings, 20 Hold Ratings, and 3 Sell Ratings. HUM average Analyst price target in the past 3 months is 348.16.
Each month's total comprises the sum of three months' worth of ratings.

HUM Financial Forecast

HUM Earnings Forecast

Next quarter’s earnings estimate for HUM is -CHF0.77 with a range of -CHF1.05 to CHF0.38. The previous quarter’s EPS was CHF6.18. HUM beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year HUM has Performed in-line its overall industry.
Next quarter’s earnings estimate for HUM is -CHF0.77 with a range of -CHF1.05 to CHF0.38. The previous quarter’s EPS was CHF6.18. HUM beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year HUM has Performed in-line its overall industry.

HUM Sales Forecast

Next quarter’s sales forecast for HUM is CHF33.21B with a range of CHF32.85B to CHF33.67B. The previous quarter’s sales results were CHF33.21B. HUM beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.01% of the time in the same period. In the last calendar year HUM has Performed in-line its overall industry.
Next quarter’s sales forecast for HUM is CHF33.21B with a range of CHF32.85B to CHF33.67B. The previous quarter’s sales results were CHF33.21B. HUM beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.01% of the time in the same period. In the last calendar year HUM has Performed in-line its overall industry.

HUM Stock Forecast FAQ

What is CH:HUM’s average 12-month price target, according to analysts?
Based on analyst ratings, Humana Inc’s 12-month average price target is 348.16.
    What is CH:HUM’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for CH:HUM, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Humana Inc a Buy, Sell or Hold?
        Humana Inc has a consensus rating of Moderate Buy, which is based on 11 buy ratings, 11 hold ratings and 1 sell ratings.
          What is Humana Inc’s share price target?
          The average share price target for Humana Inc is 348.16. This is based on 23 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is CHF505.39 ,and the lowest forecast is CHF226.78. The average share price target represents N/A Increase from the current price of N/A.
            What do analysts say about Humana Inc?
            Humana Inc’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 23 Wall Streets Analysts.
              How can I buy shares of Humana Inc?
              To buy shares of CH:HUM, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.